Rocket Pharma Mergers & Acquisitions

Rocket Pharma M&A Summary

Rocket Pharma has acquired 1 company, including 1 in the last 5 years.

Rocket Pharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Rocket Pharma

Rocket Pharmaceuticals, Inc.

9 Cedarbrook Drive,
Cranbury, New Jersey 08512
United States,
(609) 659-8001
www.rocketpharma.com

All (1) Buy (1) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2022-09-20 Renovacor · Life Science
Greenwich, Connecticut · www.renovacor.com

Renovacor is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. Renovacor is based in Greenwich, Connecticut.

Advisors: Troutman Pepper Hamilton Sanders , Wells Fargo Securities
- Add-on Acquisition

Rocket Pharma
Advisor: Goodwin Procter

-

Try Mergr Free — See This and 220,830+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.